In this context, our human CO-TDP-43 expressing fly model provides an in vivo platform to characterize and validate some of these modifiers to better understand the TDP-43-dependent disease mechanism in ALS/FTLD. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.